EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Wade Ackerman

Regulating the digital health revolution: When does it help or hinder innovation?

Covington & Burling LLP

AJ Triano

Artificial expectations? How smart is AI? Big data versus smart data and its ability to transform healthcare – Parc 55

Syneos Health

7:00am - 6:00pm 660 mins
Info
Registration and Partnering Desk Open – Parc 55

Parc 55 San Francisco, Level 4, Cyril Magnin Foyer

Please note: The registration and partnering desks will be open all day

8:00am - 6:00pm 600 mins
Info
One-to-one meetings

Please note: One-to-one meetings will take place all day depending on your partnering schedule.

8:15am - 9:00am 45 mins
Info
Regulating the digital health revolution: When does it help or hinder innovation?
  • Moderator Wade Ackerman - Partner, Covington & Burling LLP
  • Panelist Nancy Bradish Myers - President and Founder, Catalyst Healthcare Consulting
  • Panelist Mylea Charvat - CEO and Founder, Savonix
  • Panelist Michelle Jump - Principal Regulatory Affairs Specialist, Stryker
  • Panelist Beth Rogozinski - Chief Content Officer, Pear Therapeutics

Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom III

So many digital technologies are already in the hands of consumers: phone apps, health games, condition trackers, wearables, etc. There is also a new generation of digital health technologies that utilize blockchain, AI, and machine learning—these innovations are tailored to individual patients and are aimed at revolutionizing healthcare and how we treat age-old health problems. What does the evolving regulatory framework mean for companies who want to commercialize these technologies? What regulators should innovators be watching, and what are potential legislative and policy changes ahead? Will FDA's newly-established Digital Health Innovation Action Plan and recent FDA guidance protect the public, or will they end up holding back technologies that could leap forward our healthcare system?

9:00am - 10:30am 90 mins
Info
Partner Pitches: Pharma, Digital Medicine and Large Medtech Company Presentations

HOYA, MedImmune, Qualcomm Life, MindMaze and Bayer Grants4Apps

10:45am - 11:45am 60 mins
Info
Company presentations – Parc 55

Parc 55 San Francisco, Level 4, Cyril Magnin II and III

12:00pm - 1:00pm 60 mins
Info
Artificial expectations? How smart is AI? Big data versus smart data and its ability to transform healthcare – Parc 55
  • Moderator AJ Triano - Senior VP, Engagement Strategy, Communications, Syneos Health
  • Panelist Jason Bhan - Co-Founder and Chief Medical Officer, Prognos
  • Panelist Jared Josleyn - Partnerships and Business Development Lead, Verily Life Sciences
  • Panelist Christine Lemke - President and Co-Founder, Evidation Health
  • Panelist Ed Mingle - Executive Director, Global Safety Operations, Celgene
  • Panelist Dan Riskin - CEO, Verantos

Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom III

According to some market estimates, artificial intelligence applications currently represent USD 150 billion worth of efficiencies and savings for the US healthcare market by 2026. But a growing awareness of the challenges of turning big data into smart data, managing regulatory hurdles, and translating the outputs of machine learning into positive patient outcomes might take longer than once expected. From cognitive computing to behavioral analysis to brain mapping to disease diagnosis, this session will help industry stakeholders understand the most likely areas of near and long term impact by using smart data and machine learning to address the tension between what’s technologically possible and what’s genuinely probable.

1:00pm - 5:00pm 240 mins
Info
Company presentations – Parc 55

Parc 55 San Francisco, Level 4, Cyril Magnin II and III